Why Alexandria Real Estate Equities Was Diving This Week

Alexandria Real Estate Equities (NYSE: ARE) shares fell over 27% week-to-date after reporting a disappointing third quarter, marked by a nearly 5% year-over-year revenue drop to $752 million and over a 7% decline in non-GAAP FFO to $378 million. The REIT also saw average occupancy fall to 91.4% from 94.8% and lowered its 2025 adjusted FFO guidance to $9.01. This performance led BTIG to downgrade the stock to Neutral, citing concerns over declining occupancy and market oversupply.

Analysis

Alexandria Real Estate Equities (ARE) shares plummeted over 27% week-to-date following a significantly disappointing third-quarter earnings report. The REIT recorded a nearly 5% year-over-year decline in total revenue to $752 million and an over 7% slide in non-GAAP FFO to $378 million, signaling a clear deterioration in core financial performance.

Operational weakness was further evidenced by a sharp drop in average occupancy to 91.4% from 94.8% year-over-year, a substantial decline for a REIT. Management subsequently lowered its 2025 adjusted FFO guidance to $9.01 from a prior estimate of $9.26, reflecting a less optimistic outlook.

This negative performance prompted BTIG's Thomas Catherwood to downgrade ARE to Neutral from Buy, citing concerns over declining occupancy and broader market oversupply. Despite the company's focus on life sciences, these fundamental and market-specific issues contributed to the stock's severe market reaction and pessimistic sentiment.

Key Decisions for Investors

• Investors should closely monitor ARE's occupancy rates and the broader life sciences real estate market for signs of stabilization or further oversupply, given the recent decline to 91.4% and analyst concerns.
• Re-evaluate the investment thesis for ARE in light of the lowered 2025 FFO guidance and the BTIG downgrade, as these indicate potential headwinds for future profitability.
• Consider the implications of a sustained pessimistic sentiment and significant share price drop on ARE's valuation and long-term capital appreciation prospects.